Inhalant Approved for Agitation in Bipolar I, SchizophreniaInhalant Approved for Agitation in Bipolar I, Schizophrenia

FDA approves loxapine inhalation powder for acute treatment of agitation associated with schizophrenia or bipolar 1 disorder in adults. FDA Approvals (Source: Medscape Today Headlines)

Source: http://www.medworm.com/index.php?rid=6876119&cid=u_0_26_f&fid=36062&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F776682%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F776682%3Fsrc%3Drss

schools for phlebotomy phlebotomy training in michigan local phlebotomy classes